Free for academic non-profit institutions. Other users need a Commercial license
This gene encodes a liver-specific member of the organic anion transporter family. The encoded protein is a transmembrane receptor that mediates the sodium-independent uptake of endogenous and xenobiotic compounds and plays a critical role in bile acid and bilirubin transport. Mutations in this gene are a cause of Rotor type hyperbilirubinemia. Alternative splicing of this gene and the use of alternative promoters results in transcript variants encoding different isoforms that differ in their tissue specificity. [provided by RefSeq, Mar 2017]
SLCO1B3 (Solute Carrier Organic Anion Transporter Family Member 1B3) is a Protein Coding gene. Diseases associated with SLCO1B3 include Hyperbilirubinemia, Rotor Type and Gilbert Syndrome. Among its related pathways are Transport of vitamins, nucleosides, and related molecules and Statin Pathway - Generalized, Pharmacokinetics. Gene Ontology (GO) annotations related to this gene include transporter activity and organic anion transmembrane transporter activity. An important paralog of this gene is SLCO1B3-SLCO1B7.
GeneHancer (GH) Identifier | GH Type | GH Score |
GH Sources | Gene Association Score | Total Score | TSS distance (kb) | Number of Genes Away | Size (kb) | Transcription Factor Binding Sites |
Gene Targets |
---|---|---|---|---|---|---|---|---|---|---|
GH12J020822 | Promoter/Enhancer | 1 | EPDnew FANTOM5 ENCODE | 622.4 | +11.8 | 11771 | 0.4 | SIN3A POLR2A | SLCO1B3 piR-36770-023 SLCO1B3-SLCO1B7 NONHSAG010647.2 ENSG00000256157 SLCO1B7 | |
GH12J020810 | Promoter | 0.4 | EPDnew | 600.7 | 0.0 | -16 | 0.1 | TAF1 | NONHSAG010647.2 SLCO1B3 HSALNG0089740 SLCO1C1 | |
GH12J020808 | Promoter | 0.3 | EPDnew | 600.7 | -3.2 | -3201 | 0.1 | SLCO1B3 HSALNG0089740 NONHSAG010647.2 SLCO1C1 | ||
GH12J020807 | Promoter | 0.3 | EPDnew | 600.7 | -3.0 | -2965 | 0.1 | SLCO1B3 HSALNG0089740 NONHSAG010647.2 SLCO1C1 | ||
GH12J020875 | Promoter | 0.3 | EPDnew | 600.2 | +64.7 | 64711 | 0.1 | SLCO1B3 piR-38005-006 SLCO1B3-SLCO1B7 lnc-SLCO1A2-5 NONHSAG010647.2 SLCO1B7 |
GO ID | Qualified GO term | Evidence | PubMed IDs |
---|---|---|---|
GO:0005515 | protein binding | IEA | -- |
GO:0008514 | organic anion transmembrane transporter activity | TAS | 10779507 |
GO:0015125 | bile acid transmembrane transporter activity | TAS | -- |
GO:0015347 | sodium-independent organic anion transmembrane transporter activity | IBA | 21873635 |
GO ID | Qualified GO term | Evidence | PubMed IDs |
---|---|---|---|
GO:0005886 | plasma membrane | TAS | -- |
GO:0005887 | integral component of plasma membrane | TAS,IBA | 21873635 |
GO:0016020 | membrane | IEA | -- |
GO:0016021 | integral component of membrane | IEA | -- |
GO:0016323 | basolateral plasma membrane | IEA | -- |
GO ID | Qualified GO term | Evidence | PubMed IDs |
---|---|---|---|
GO:0006811 | ion transport | IEA | -- |
GO:0015711 | organic anion transport | TAS | 10779507 |
GO:0015721 | bile acid and bile salt transport | TAS | -- |
GO:0043252 | sodium-independent organic anion transport | TAS | -- |
GO:0055085 | transmembrane transport | IEA | -- |
Name | Status | Disease Links | Group | Role | Mechanism of Action | Clinical Trials |
---|---|---|---|---|---|---|
Rifampicin | Approved | Pharma | Agonist, Inhibitor, Inhibition, Transporter, substrate, inhibitor, binder | Pregnane X receptor agonist; antibiotic | 456 | |
Cyclosporin A | Approved, Investigational, Vet_approved | Pharma | Antagonist, Inhibitor, Inhibition, Transporter, inhibitor | Immunosuppressive agent, Calcineurin inhibitor | 0 | |
Gemfibrozil | Approved | Pharma | Agonist, Inhibitor, Inhibition, Target, inhibitor, activator | 30 | ||
Docetaxel | Approved, Investigational | Pharma | Transporter, substrate | Microtubulin disassembly inhibitor, Tubulin and VEGF inhibitor, Taxanes | 2330 | |
Mycophenolate mofetil | Approved, Investigational | Pharma | Transporter, substrate | IMPDH inhibitor | 0 |
Name | Synonyms | Role | CAS Number | PubChem IDs | PubMed IDs | |
---|---|---|---|---|---|---|
(3a,5b,7a)-23-Carboxy-7-hydroxy-24-norcholan-3-yl-b-D-Glucopyranosiduronic acid |
|
58814-71-4 |
|
|||
1,3,12-Trihydroxycholan-24-oic acid |
|
63266-91-1 |
|
|||
1,3,7,12-Tetrahydroxycholan-24-oic acid |
|
63266-89-7 |
|
|||
12a-Hydroxy-3-oxocholadienic acid |
|
13535-96-1 |
|
|||
12b-Hydroxy-5b-cholanoic acid |
|
15173-23-6 |
|
Compound | Action | Cas Number |
---|---|---|
Probenecid | 57-66-9 |
This gene was present in the common ancestor of chordates.
Organism | Taxonomy | Gene | Similarity | Type | Details |
---|---|---|---|---|---|
Dog (Canis familiaris) |
Mammalia | SLCO1B3 30 |
|
||
OATPC 31 |
|
OneToMany | |||
Cow (Bos Taurus) |
Mammalia | SLCO1B3 30 |
|
||
-- 31 |
|
OneToMany | |||
Mouse (Mus musculus) |
Mammalia | Slco1b2 30 17 31 |
|
OneToMany | |
Rat (Rattus norvegicus) |
Mammalia | Slco1b2 30 |
|
||
Platypus (Ornithorhynchus anatinus) |
Mammalia | -- 31 |
|
OneToMany | |
Oppossum (Monodelphis domestica) |
Mammalia | -- 31 |
|
OneToMany | |
Chicken (Gallus gallus) |
Aves | -- 31 |
|
OneToMany | |
Lizard (Anolis carolinensis) |
Reptilia | -- 31 |
|
OneToMany |
SNP ID | Clinical significance and condition | Chr 12 pos | Variation | AA Info | Type |
---|---|---|---|---|---|
712105 | Conflicting Interpretations: Rotor syndrome; not provided | 20,855,146(+) | T/TAATTG | FRAMESHIFT_VARIANT | |
719501 | Benign: Rotor syndrome; not provided | 20,815,807(+) | C/T | SYNONYMOUS_VARIANT | |
722875 | Conflicting Interpretations: Rotor syndrome; not specified; not provided | 20,883,599(+) | T/C | MISSENSE_VARIANT | |
724243 | Conflicting Interpretations: Rotor syndrome; not provided | 20,877,875(+) | C/T | SYNONYMOUS_VARIANT | |
727114 | Conflicting Interpretations: Rotor syndrome; not provided | 20,877,902(+) | C/T | SYNONYMOUS_VARIANT |
Disorder | Aliases | PubMed IDs |
---|---|---|
hyperbilirubinemia, rotor type |
|
|
gilbert syndrome |
|
|
progressive familial intrahepatic cholestasis |
|
|
intrahepatic cholestasis of pregnancy |
|
|
hepatocellular adenoma |
|
|